Handbook of Incretin-based Therapies in Type 2 Diabetes

  • Stephen Gough

Table of contents

  1. Front Matter
    Pages I-IX
  2. Sunder Mudaliar, Robert R. Henry
    Pages 1-9
  3. Jens Juul Holst
    Pages 11-30
  4. Baptist Gallwitz
    Pages 31-43
  5. Carolyn F Deacon
    Pages 45-60
  6. Archana Dhere, Stephen C. L. Gough
    Pages 61-75
  7. Eduard Montanya
    Pages 77-92

About this book

Introduction

This concise handbook provides an overview of incretin-based therapies and guidance for incorporating them into the treatment of type 2 diabetes. Chapters include landmark clinical trials and international treatment guidelines in order to update readers with all major advances in the field. An ideal resource for medical professionals that treat patients with type 2 diabetes in hospital and clinical settings.

Keywords

Diabetes Type 2 diabetes DPP-4 inhibitor GLP-1 analogue Incretin Dipeptidyl peptidase-4 inhibitor Gliptins Glucagon-like peptide-1 agonist Incretin mimetics Oral hypoglycemics Oral antidiabetics Sitagliptin Saxagliptin Vildagliptin Alogliptin Linagliptin Exenatide Liraglutide Lixisenatide Dulaglutide

Editors and affiliations

  • Stephen Gough
    • 1
  1. 1.Oxford Ctre for Diabe, Endocrngy & MetabOxford UniversityOxfordUnited Kingdom

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-08982-9
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Adis, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-08981-2
  • Online ISBN 978-3-319-08982-9
  • About this book
Industry Sectors
Biotechnology
Consumer Packaged Goods
Pharma